Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
This product is supplied strictly for laboratory, cosmetic and research purposes only
The peptide's peak neurotransmitter effects occur within 2-6 hours of injection
As monotherapy , a multicentre, randomised, double-blind, placebo-controlled and active-controlled Phase 2 dose-finding trial enrolled 706 adults with overweight or obesity (without diabetes) to once-weekly subcutaneous cagrilintide across doses of 0.3 to 4.5 mg over 26 weeks
It has special value in the exploration and application of biomedical research and fitness fields, and its production, application, and control must comply with strict regulations related to biological products
US$ 23.32
US$ 25.97
US$ 27.44
US$ 27.71
